Repeated Thrombolysis for Chronologically Separated Ischemic Strokes
Author(s) -
Roland Sauer,
Hagen B. Huttner,
Lorenz Breuer,
Tobias Engelhorn,
Peter D. Schellinger,
Stefan Schwab,
Martin Köhrmann
Publication year - 2010
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.110.585067
Subject(s) - medicine , thrombolysis , stroke (engine) , pulmonary embolism , tissue plasminogen activator , myocardial infarction , infarction , recombinant tissue plasminogen activator , cardiology , ischemic stroke , ischemia , surgery , anesthesia , mechanical engineering , engineering , modified rankin scale
Recombinant tissue plasminogen activator is used for the treatment of acute myocardial infarction, pulmonary embolism, and acute ischemic stroke. With many years since approval of the drug and an aging population, chances increase that patients are treated twice for chronologically separated events.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom